|
Market Closed -
Oslo Bors
10:45:00 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 14.65 NOK | +2.45% |
|
-5.79% | -38.45% |
| 08-14 | Navamedic ASA, Q2 2026 Earnings Call, Aug 14, 2026 | |
| 08-14 | Navamedic Asa Provides Earnings Guidance for the Year 2026 | CI |
Company Valuation: Navamedic ASA
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 555.8 | 601.2 | 636.8 | 453.9 | 570.8 | 351.3 | - | - |
| Change | - | 8.19% | 5.92% | -28.72% | 25.74% | -38.45% | - | - |
| Enterprise Value (EV) 1 | 542.1 | 597.9 | 745.4 | 453.9 | 702.3 | 470.8 | 448.2 | 403.2 |
| Change | - | 10.3% | 24.65% | -39.1% | 54.71% | -32.96% | -4.8% | -10.04% |
| P/E | 850x | 20.2x | 195x | - | -19.3x | -54.6x | 46.9x | 14.1x |
| PBR | - | 2.87x | 2.86x | 2.1x | - | 1.14x | 1.12x | 1.02x |
| PEG | - | 0x | -2.2x | - | - | 0.7x | -0x | 0x |
| Capitalization / Revenue | 2x | 1.57x | 1.24x | 0.85x | 1.01x | 0.62x | 0.58x | 0.54x |
| EV / Revenue | 1.95x | 1.56x | 1.46x | 0.85x | 1.24x | 0.83x | 0.74x | 0.62x |
| EV / EBITDA | 29.8x | 11.6x | 14.5x | 9.75x | 14.8x | 8.56x | 6.92x | 4.92x |
| EV / EBIT | 47.3x | 13.5x | 18.8x | 18.8x | 56.6x | 52.6x | 16.8x | 8.68x |
| EV / FCF | -267x | 38.1x | -7.28x | 12.8x | -4.36x | 10.7x | 9.36x | 7.07x |
| FCF Yield | -0.37% | 2.62% | -13.7% | 7.84% | -22.9% | 9.35% | 10.7% | 14.1% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.04 | 1.73 | 0.188 | - | -1.236 | -0.2682 | 0.3125 | 1.038 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 278.4 | 382.1 | 512 | 531.4 | 565.4 | 569.8 | 603.9 | 651.8 |
| EBITDA 1 | 18.2 | 51.69 | 51.57 | 46.55 | 47.61 | 54.99 | 64.74 | 82.04 |
| EBIT 1 | 11.46 | 44.44 | 39.64 | 24.13 | 12.4 | 8.951 | 26.64 | 46.44 |
| Net income 1 | 0.618 | 29.43 | 3.814 | 1.29 | -23.54 | -6.496 | 7.698 | 24.96 |
| Net Debt 1 | -13.64 | -3.304 | 108.5 | - | 131.5 | 119.5 | 96.9 | 51.9 |
| Reference price 2 | 34.00 | 34.90 | 36.70 | 25.70 | 23.80 | 14.65 | 14.65 | 14.65 |
| Nbr of stocks (in thousands) | 16,346 | 17,228 | 17,353 | 17,663 | 23,981 | 23,981 | - | - |
| Announcement Date | 2/17/22 | 2/16/23 | 2/15/24 | 2/12/25 | 2/12/26 | - | - | - |
1NOK in Million2NOK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -54.62x | 0.83x | 8.56x | - | 37.48M | |
| 33.44x | 12.14x | 24.6x | 0.59% | 1,047B | |
| 29.82x | - | - | 2% | 646B | |
| 32.61x | 7.57x | 15.74x | 2.68% | 451B | |
| 19.99x | 4.75x | 11.76x | 2.79% | 355B | |
| 21.76x | 5.62x | 13.93x | 2.85% | 291B | |
| 20.88x | 4.29x | 12.24x | 2.06% | 252B | |
| 27.35x | 7.07x | 12.56x | 2.33% | 234B | |
| 13.25x | 4.77x | 9.95x | 3.83% | 203B | |
| -44.51x | 6.43x | 25.11x | 2.26% | 181B | |
| Average | 10.00x | 5.94x | 14.94x | 2.38% | 365.93B | |
| Weighted average by Cap. | 24.24x | 8.07x | 17.81x | 1.97% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- NAVA Stock
- Valuation Navamedic ASA
Select your edition
All financial news and data tailored to specific country editions
